(Q37336859)

19 August 2017

1 reference

title

New-onset diabetes mellitus after solid organ transplantation (English)

1 reference

19 August 2017

main subject

organ transplantation

1 reference

Kenneth A Bodziak

1

1 reference

19 August 2017

Donald E Hricik

series ordinal

2

1 reference

19 August 2017

publication date

20 November 2008

1 reference

19 August 2017

published in

Transplant International

1 reference

19 August 2017

volume

22

1 reference

19 August 2017

issue

5

1 reference

19 August 2017

page(s)

519-530

1 reference

Transplant-associated hyperglycemia: a new look at an old problem

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplantation diabetes: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

New-onset cardiovascular risk factors in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Risk for posttransplant Diabetes mellitus with current immunosuppressive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels: effects on cell cycle progression in rodent islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Rapamycin impairs in vivo proliferation of islet beta-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Variables affecting weight gain in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplant diabetes mellitus in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Predictive factors for development of diabetes mellitus post-heart transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Predicting the occurrence of diabetes mellitus in recipients of heart transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Guidelines for the treatment and management of new-onset diabetes after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Should an oral glucose tolerance test be performed routinely in all renal transplant recipients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Clinical practice. Initial management of glycemia in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2008.00800.X

10.1111/J.1432-2277.2008.00800.X

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference